Table 2.
Model | Entry | Repli-Cation | Progeny Release | Pros | Cons | Ref. |
---|---|---|---|---|---|---|
Transfected HuH7 | − | + | + 1 | Easy access/handling | Does not reflect authentic infection | [42,43,44,45] |
PHH | + | + | + 2 | Natural host; most physiological | Limited availability; High donor-to-donor variability | [39,40,41] |
HepaRG | + | + | + 2 | Exhibit some hepatic function; fully support innate immunity | Requires elaborate differentiation protocol; only hepatocyte-like cells are susceptible | [46] |
HuH7/HepG2-hNTCP | + | + | + 2 | Easy access/handling; efficient infection | Only partially resemble hepatocytes | [13] |
Stem-cell derived hepatocytes | + | + | ? | Same donor can be used for different experiments; physiologically close to PHH | Requires elaborate differentiation protocol; ethical concerns in some countries | [47,48,49,50,51] |
1 when co-transfected with a plasmid encoding HBsAg; 2 when co-infected with HBV. PHH: primary human hepatocytes.